The global Veterinary Oncology market size is expected to be worth around US$ 447.0 million by 2027, according to a new report by Vision Research Reports.
The global Veterinary Oncology market size was valued at US$ 199.9 million in 2019 and is anticipated to grow at a CAGR of 10.7% during forecast period 2020 to 2027.
The increasing pervasiveness of cancer in the pet population and rising adoption of veterinary cancer therapy as a treatment method are propelling market growth. Growing expenditure on animal healthcare in the developed economies due to rising willingness to spend on pet healthcare by owners and initiatives by government for the veterinary cancer treatment are the major factors driving the market growth.
Growth Factors
Increasing prevalence of cancer in pets and demand for veterinary diagnostics are projected to drive the market over the forecast period.
Adoption of canine cancer registry globally to estimate cancer incidences is another driving factor for the market growth. According to frontiers in Veterinary Science in February 2019, the Swiss Canine Cancer Registry (SCCR) was used as a data source and was compiled for future comparative studies of canine and human cancers. This database is further helpful in mitigating the incidence of malignant tumors in the human population, thereby driving the market growth.
Report Highlights
Increasing prevalence of cancer in animals, clinical trial studies to evaluate safety and effectiveness of cancer therapeutics, and technological advancements in veterinary oncology treatment are anticipated to create growth opportunities in the market
The chemotherapy segment is anticipated to account for the largest revenue share over the coming years owing to its increasing adoption either alone or in combination with other therapies
The canine segment held the largest revenue in 2019 owing to increasing population of dogs and high prevalence of cancer in dogs as compared to cats
Lymphoma dominated the market among other cancer types in 2019, due to high mortality rate in companion animals
North America held the dominant share of the veterinary oncology market in 2019, due to favorable government policies, new product launches, and huge investment in oncology treatment
Key Players
PetCure Oncology; Elanco; Accuray Incorporated; Varian Medical Systems; Zoetis; Karyopharm Therapeutics, Inc.; One Health; and Regeneus Ltd.
Market Segmentation
Veterinary Oncology Therapy Outlook
Surgery
Radiology
Chemotherapy
Immunotherapy
Others (Combination Therapy, Targeted Therapy)
Veterinary Oncology Animal Type Outlook
Canine
Feline
Veterinary Oncology Cancer Type Outlook
Lymphoma
Mast Cell Cancer
Mammary and Squamous Cell Cancer
Others (Anal Sac Carcinoma)
Veterinary Oncology Regional Outlook
North America
U.S.
Canada
Europe
U.K.
Germany
Asia Pacific
Latin America
Middle East & Africa
The Veterinary Oncology market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Veterinary Oncology market for the base year 2019 and the forecast between 2020 and 2027. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Veterinary Oncology market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Veterinary Oncology market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Veterinary Oncology market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Veterinary Oncology capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Veterinary Oncology by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Veterinary Oncology market. These figures have been provided in terms of both revenue and volume for the period 2016 to 2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Veterinary Oncology market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Veterinary Oncology market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Veterinary Oncology industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Veterinary Oncology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Veterinary Oncology market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Veterinary Oncology market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Veterinary Oncology market. These factors have benefited the growth of the global market for Veterinary Oncology. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Veterinary Oncology. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Veterinary Oncology are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Veterinary Oncology Market, By Therapy
7.1. Veterinary Oncology Market, By Therapy Type, 2020-2030
7.1.1. Surgery
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Radiology
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Chemotherapy
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Immunotherapy
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. Others (Combination Therapy, Targeted Therapy)
7.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Veterinary Oncology Market, By Animal Type
8.1. Veterinary Oncology Market, By Animal Type, 2020-2030
8.1.1. Canine
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Feline
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Veterinary Oncology Market, By Cancer Type
9.1. Veterinary Oncology Market, By Cancer Type, 2020-2030
9.1.1. Lymphoma
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Mast Cell Cancer
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Mammary and Squamous Cell Cancer
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Others (Anal Sac Carcinoma)
9.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Veterinary Oncology Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.1.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.1.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.1.4.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.1.4.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.1.5.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.1.5.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.2.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.2.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.2.4.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.2.4.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.2.5.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.2.5.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.2.6.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.2.6.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.2.7.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.2.7.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.3.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.3.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.3.4.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.3.4.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.3.5.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.3.5.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.3.6.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.3.6.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.3.7.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.3.7.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.4.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.4.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.4.4.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.4.4.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.4.5.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.4.5.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.4.6.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.4.6.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.4.7.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.4.7.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.5.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.5.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.5.4.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.5.4.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Therapy (2016-2030)
10.5.5.2. Market Revenue and Forecast, By Animal Type (2016-2030)
10.5.5.3. Market Revenue and Forecast, By Cancer Type (2016-2030)
Chapter 11. Company Profiles
11.1. PetCure Oncology
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Elanco
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Accuray Incorporated
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Varian Medical Systems
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Zoetis
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Karyopharm Therapeutics, Inc
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. One Health
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Regeneus Ltd
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms